(Q37692660)

22 August 2017

1 reference

title

Non-small-cell lung cancer harbouring mutations in the EGFR kinase domain (English)

1 reference

22 August 2017

1 reference

1

Rafael Rosell

1 reference

22 August 2017

Teresa Morán

2

1 reference

22 August 2017

Enric Carcereny

3

1 reference

22 August 2017

Vanessa Quiroga

4

1 reference

22 August 2017

Miguel Angel Molina

5

1 reference

22 August 2017

Carlota Costa

6

1 reference

22 August 2017

Susana Benlloch

7

1 reference

22 August 2017

Miquel Tarón

8

1 reference

22 August 2017

1 February 2010

1 reference

Clinical and Translational Oncology

22 August 2017

1 reference

22 August 2017

12

1 reference

22 August 2017

2

1 reference

22 August 2017

75-80

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-010-0473-0

22 August 2017

0 references

cites work

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

1 reference

12 December 2020

Screening for epidermal growth factor receptor mutations in lung cancer

1 reference

12 December 2020

Suppression of non-small cell lung tumor development by the let-7 microRNA family

1 reference

12 December 2020

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

1 reference

12 December 2020

Selective blockade of microRNA processing by Lin28

1 reference

12 December 2020

Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis

1 reference

12 December 2020

Tumors line up for a letdown.

1 reference

12 December 2020

Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer

1 reference

12 December 2020

Epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in advanced nonsmall-cell lung cancer

1 reference

12 December 2020

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

1 reference

12 December 2020

MicroRNAs in the pathogenesis of Lung Cancer

1 reference

12 December 2020

Personalized medicine and inhibition of EGFR signaling in lung cancer

1 reference

12 December 2020

Lin28 promotes transformation and is associated with advanced human malignancies

1 reference

12 December 2020

Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer.

1 reference

12 December 2020

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib

1 reference

12 December 2020

Let-7 expression defines two differentiation stages of cancer

1 reference

12 December 2020

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancers dependent on the epidermal growth factor receptor pathway.

1 reference

12 December 2020

Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations.

1 reference

12 December 2020

A role for Lin28 in primordial germ-cell development and germ-cell malignancy

1 reference

12 December 2020

Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients

1 reference

12 December 2020

Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer.

1 reference

12 December 2020

The let-7 microRNA represses cell proliferation pathways in human cells

1 reference

12 December 2020

Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile

1 reference

12 December 2020

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

1 reference

12 December 2020

First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations

1 reference

12 December 2020

Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancer

1 reference

12 December 2020

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

12 December 2020

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

1 reference

12 December 2020

Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.

1 reference

12 December 2020

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

1 reference

12 December 2020

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

12 December 2020

MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases

1 reference

12 December 2020

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

1 reference

12 December 2020

A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells

1 reference

12 December 2020

Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer

1 reference

12 December 2020

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

1 reference

12 December 2020

MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers

1 reference

12 December 2020

Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation

1 reference

12 December 2020

Detection of mutations in EGFR in circulating lung-cancer cells

1 reference

12 December 2020

Stem cells, cancer, and cancer stem cells

1 reference

12 December 2020

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials

1 reference

12 December 2020

Transcriptional profiling identifies cyclin D1 as a critical downstream effector of mutant epidermal growth factor receptor signaling

1 reference

12 December 2020

Peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based detection test for gefitinib-refractory T790M epidermal growth factor receptor mutation.

1 reference

12 December 2020

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

12 December 2020

Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines

1 reference

12 December 2020

Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened

1 reference

12 December 2020

Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer

1 reference

12 December 2020

10.1007/S12094-010-0473-0

Identifiers

DOI

1 reference

22 August 2017

1 reference